<DOC>
	<DOCNO>NCT00042406</DOCNO>
	<brief_summary>The purpose study determine whether HuMax-CD4 effective treatment active rheumatoid arthritis patient fail treatment Methotrexate least one TNF-alpha blocking agent .</brief_summary>
	<brief_title>Trial With HuMax-CD4 Patients With Rheumatoid Arthritis Failing Treatment With Methotrexate TNF-alpha Blocker</brief_title>
	<detailed_description>This multi-center , double-blind , placebo-controlled , parallel-group , randomized trial HuMax-CD4 treatment patient active rheumatoid arthritis ( RA ) fail treatment Methotrexate ( MTX ) least one TNF-alpha blocking agent . Patients randomize receive one two dose HuMax-CD4 placebo . The drug administer subcutaneous infusion ( give skin ) , often begin follow maintenance dose . There 4 week follow period , final evaluation clinical endpoint take place 26 week treatment start . The trial last 28 week .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>A diagnosis rheumatoid arthritis accord American College Rheumatology 1987 revise criterion ( ACR ) least 6 month duration . Active disease time screen . Unable tolerate Methotrexate , lack efficacy minimum 6 month treatment . Failure tolerate treatment either Enbrel Remicade , lack efficacy least 3 month treatment one agent . Active autoimmune disease require therapy ( rheumatoid arthritis secondary Sj√∂gren 's disease ) . The use certain treatment drug treatment rheumatoid arthritis within 4 week participation trial . Syndromes Fibromyalgia require chronic pain treatment . Most past current cancer . Chronic current infectious disease , limited , chronic renal infection , chronic chest , nasal throat infection , tuberculosis , hepatitis B C. History infect joint prosthesis within 5 year . Most active medical condition heart disease , kidney disease , liver disease , blood disease , hormonal disturbance , lung disease , psychiatric disease . Drug alcohol abuse . Pregnant breastfeed woman may participate . Women childbearing potential must use either contraceptive pill intrauterine device entire study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>